Study on efficacy and safety as well as on the changes in blood purine compounds by the treatment of patients with amyotrophic lateral sclerosis with febuxostat and inosine in combination. Study on efficacy and safety as well as on the changes in blood purine compounds by the treatment of ...
Study on efficacy and safety as well as on the changes in blood purine compounds by the treatment of patients with amyotrophic lateral sclerosis with febuxostat and inosine in combination. - Effect of febuxostat and inosine on amyotrophic lateral sclerosis Study on efficacy and safety as well as on the changes in blood purine compounds by the treatment of ...
Studies of efficacy and safety of the combined use of febuxostat and inosine for patients with Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis or multiple sclerosis, and changes of blood and urine purine compounds. Studies of efficacy and safety of the combined use of febuxostatand inosine for patients with Alzhei ...
Studies of efficacy and safety of the combined use of febuxostat and inosine for patients with Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis or multiple sclerosis, and changes of blood and urine purine compounds. - Effect of febuxostat and inosine on CNS diseases Studies of efficacy and safety of the combined use of febuxostatand inosine for patients with Alzhei ...
Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis or multiple sclerosis
Treatment with febuxostat 20 mg and inosine 0.5 g, twice a day for 2 weeks
Tsukuba International Clinical Pharmacology Clinic